Fortrea (NASDAQ:FTRE) Upgraded to Hold at Barclays

Fortrea (NASDAQ:FTRE - Get Free Report) was upgraded by investment analysts at Barclays from a "strong sell" rating to a "hold" rating in a report issued on Monday,Zacks.com reports.Other analysts have also recently issued reports about the company. Evercore ISI set a $14.00 price target on Fortrea in a report on Thursday, November 6th. Mizuho set a $11.00 target price on Fortrea in a report on Friday, November 7th. Robert W. Baird upped their price target on shares of Fortrea from $9.00 to $14.00 and gave the company an "outperform" rating in a research note on Wednesday, September 3rd. Citigroup upgraded shares of Fortrea from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $12.00 to $21.00 in a research note on Thursday. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Fortrea in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $13.06.Get Our Latest Research Report on FortreaFortrea Stock PerformanceNASDAQ FTRE opened at $16.06 on Monday. The stock has a market cap of $1.48 billion, a PE ratio of -1.43, a P/E/G ratio of 0.74 and a beta of 1.75. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.00 and a current ratio of 1.00. The firm has a 50-day moving average of $11.52 and a 200-day moving average of $8.69. Fortrea has a 52-week low of $3.97 and a 52-week high of $20.86. Fortrea (NASDAQ:FTRE - Get Free Report) last released its quarterly earnings results on Wednesday, November 5th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $701.30 million during the quarter, compared to the consensus estimate of $643.43 million. Fortrea had a negative net margin of 36.77% and a positive return on equity of 5.64%. On average, sell-side analysts anticipate that Fortrea will post 0.51 EPS for the current year. Institutional Trading of FortreaInstitutional investors and hedge funds have recently made changes to their positions in the company. Dynamic Technology Lab Private Ltd bought a new position in shares of Fortrea in the 1st quarter valued at $575,000. AQR Capital Management LLC raised its position in Fortrea by 181.9% in the first quarter. AQR Capital Management LLC now owns 1,095,282 shares of the company's stock valued at $8,269,000 after purchasing an additional 706,779 shares during the last quarter. Brandes Investment Partners LP boosted its stake in shares of Fortrea by 72.8% during the second quarter. Brandes Investment Partners LP now owns 224,272 shares of the company's stock valued at $1,108,000 after purchasing an additional 94,448 shares in the last quarter. Millennium Management LLC raised its holdings in Fortrea by 1,625.8% in the 1st quarter. Millennium Management LLC now owns 3,499,220 shares of the company's stock valued at $26,419,000 after buying an additional 3,296,461 shares during the last quarter. Finally, Voya Investment Management LLC boosted its position in Fortrea by 134.9% during the 1st quarter. Voya Investment Management LLC now owns 303,901 shares of the company's stock worth $2,294,000 after buying an additional 174,549 shares during the period. Fortrea Company Profile (Get Free Report)Fortrea Holdings Inc, a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum.Featured StoriesFive stocks we like better than Fortrea3 Grocery Stocks That Can Help Take a Bite Out of Inflation ServiceNow’s $7 Billion Gamble: Panic or Opportunity?How to Profit From Growth Investing Dell and HP Are Raising Prices—And Investors Should Take NoteHow to Use High Beta Stocks to Maximize Your Investing ProfitsWhy DLocal Is the Top Emerging Market Fintech Stock to Watch for 2026This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Fortrea Right Now?Before you consider Fortrea, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fortrea wasn't on the list.While Fortrea currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here